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Sutherlandia frutescens (SF), an indigenous medicinal plant to South Africa (SA), is traditionally used 
to treat a diverse range of illnesses including cancer and viral infections. The biologically active 
compounds of SF are polar, thus renal elimination increases susceptibility to toxicity. This study 
investigated the antioxidant potential, lipid peroxidation, mitochondrial membrane potential and 
apoptotic induction by SF on proximal and distal tubule epithelial cells. Cell viability was determined 
using the MTT assay.  Mitochondrial membrane potential was determined using a flow cytometric JC-
1 Mitoscreen assay. Cellular glutathione and apoptosis were measured using the GSH-GloTM 
Glutathione assay and Caspase-Glo® 3/7 assay, respectively. The IC50 values from the cell viability 
results for LLC-PK1 and MDBK was 15 mg/ml and 7 mg/ml, respectively. SF significantly decreased 
intracellular GSH in LLC-PK1 (p < 0.0001) and MDBK (p < 0.0001) cells. Lipid peroxidation 
increased in LLC-PK1 (p < 0.0001) and MDBK (p < 0.0001) cells. JC-1 analysis showed that SF 
promoted mitochondrial membrane depolarization in both LLC-PK1 and MDBK cells up to 80% (p < 
0.0001). The activity of caspase 3/7 increased both LLC-PK1 (11.9-fold; p < 0.0001) and MDBK (2.2-
fold; p < 0.0001) cells.  SF at high concentrations plays a role in increased oxidative stress, altered 
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Customarily, toxicology has been termed “the science of poisons” (Langman and Kapur, 2006). This 
science engages studying the properties of chemicals and the impact of these molecules on living 
organisms. Toxicological studies have provided a tool which considers the potential undesirable 
effects of chemicals in order to maintain and protect human health (Roberfroid, 1995). 
 
Historically, toxicology dates as far back as 300 B.C where early man used animal venoms and plant 
extracts for hunting and as “bio-weapons” during war. Plant extracts formed the basis of therapeutics 
and experimental medicine during the early centuries. The discipline of toxicology integrates the 
understanding and applications of the biological sciences, chemistry, physics and mathematics to test 
its theories. Toxicology differs from other sciences with the absence of a single goal but its 
diversification has allowed for the interspersion of ideas and concepts from academe, industry as well 
as government. This gives the discipline of toxicology a unique but highly advantageous slant (Amdur 
et al., 1991).  
 
The majority of Africa’s population reside in rural areas where there is a lack of basic health care 
facilities.  These people are thus reliant on traditional remedies to treat a range of diseases. Traditional 
healers make use of herbal medicines despite the lack of evidence for its safety. It is therefore 
imperative that the identification, efficacy, therapeutic doses, toxicity, standardisation and regulation 
of these plants and their extracts be determined (Chattopadhyay, 2003).  
 
The popular multi-purpose herbal remedy used by South Africans is Sutherlandia frutescens (SF).  
Sutherlandia frutescens is believed to have therapeutic potential against viral diseases, cancer, diabetes 
and a range of other conditions (Fernandes et al., 2004). Herbal remedies are currently receiving much 
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attention from the general public so much so, that these remedies are being made available in urban 
areas in the form of tablets. The spotlight, however, has shifted from the traditional conclusions of 
efficacy to the laboratories where experimentation will either prove or disprove the therapeutic 


























1.1 Sutherlandia frutescens  
Traditional medicine is a common resort of majority of Africans that require healthcare as it is difficult 
and unaffordable to access healthcare facilities (Ojewole, 2008). In 2005 Mills et al. reported that 
approximately half of all pharmaceuticals were derived from plants. The diverse array of medicinal 
plants found in South Africa is estimated to be approximately 3 000 and is used regularly by the rural 
populace (van Wyk, 2008). A popular medicinal plant which is now commercially available due to its 
multi-purpose uses is SF. This plant has been used for a long time and it is assumed to be safe (Mills et 
al., 2005). The chemistry, pharmacology and toxicity of SF extracts are currently under critical 
analysis due to the increased usage and assumed safety of SF.   
  
 1.1.1 Adaptogenic properties, Uses and Distribution of Sutherlandia  frutescens 
Sutherlandia frutescens also referred to as the ‘cancer bush’ has been used for years by traditional 
healers to treat a variety of ailments. These include internal cancers, diabetes, uterine disease, 
influenza, human immunodeficiency virus (HIV) infection, depression, and arthritis (Gericke et al., 
2001).  
 
Sutherlandia frutescens belongs to the family: Fabraceae/Leguminosa and is one of five currently 
recognised Sutherlandia species, all of which are indigenous to South Africa. This plant is distributed 






The recommended therapeutic dose of SF leaf powder for humans is 9mg/kg body weight/day with no 
side effects (Sia, 2004). This was determined during a toxicity study conducted on vervet monkeys 
(Medical Research Council and National Research Foundation of South Africa, 2002). During this 
study the dosage was increased nine times with no resulting haematological, clinical and physiological 
toxicity (Mills et al., 2005).  
 
A clinical trial conducted on healthy human volunteers showed no significant adverse changes in 
parameters following a daily dose of 800mg for 3 months (Ojewole, 2008).  The commercially 
available SF tablet has a recommended dosage of 600mg/day. 
 
1.1.3 Description and Biologically Significant Components of  Sutherlandia frutescens 
Sutherlandia frutescens is a perennial short-lived shrub that grows between 0.2-2.5m in height and has 
petiolate, stipulate and pinnate leaflets of 8-10 pairs with a terminal leaflet. Red and, seldomly white, 
flowers bear in axillary racemes and produces large and bladder-like pods containing numerous brown, 
laterally compressed, kidney shaped seeds. Leaves of SF are mainly used traditionally but all aerial 
parts are thought to have medicinal properties.  
 
Biologically active compounds that have been isolated from SF include pinitol, flavonoids, saponins 
and amino acids such as gamma-amino-butyric-acid (GABA), L-canavanine (van Wyk, 2008), 
arginine, asparagine, proline, alanine, leucine, tryptophan and phenylalanine (Tai et al., 2004). Other 
components of SF, along with commonly found plant-derived alcohols, include hexadecanoic acid, 





L-canavanine is found at approximately 14.5mg per gram of dry SF leaves (van Wyk and Albrecht, 
2008) and 3mg per gram in Phytonova SU1 SF tablets. Most leguminous plants in the subdivision 
Leguminosae synthesise L-canavanine (Bence and Crooks, 2003) which is a storage form of nitrogen 
in plant seeds and is used in the chemical defence mechanisms (Rosenthal, 1977).  
 
 L-canavanine is the L-2 amino-4-guanidinooxy structural analogue of L-arginine. The electron density 
of the guanidino group is reduced due to the destabilising effect of the oxygen atom (Bence and 
Crooks, 2003). As a result, the guanidino group of L-arginine has a pKa of 12.48 compared to 7.05 for 
the oxyguanidino group of L-canavanine (Swaffar et al., 1994). This makes L-canavanine less basic 
than L-arginine and exists in the amino, instead of the imino tautomeric form. These simple 
differences have huge implications with regard to their physiological roles. L-arginine is an important 
amino acid that is necessary for the normal development and growth of cells (Bence and Crooks, 2003) 
while L-canavanine is cytotoxic (Swaffar et al., 1994).  
 
L-canavanine has been shown to be a potent inhibitor of inducible nitric oxide synthase (NOS) 
(Lincoln et al., 1997), as well as other arginine-utilising enzymes (Hrabak et al., 1994). Nitric oxide 
synthase utilises L-arginine for the biosynthesis of nitric oxide (NO) and L-citrulline. The NOS 
reaction occurs in two steps, each using molecular oxygen (O2) and reduced NADPH as co-substrates 
(Luzzi and Marletta, 2005). L-canavanine, a substrate in the NOS reaction, is converted to L-
homoserine by the enzyme.  
 
L-canavanine is responsible for structural changes induced in proteins when it is incorporated into a 
growing peptide chain in place of L-arginine. The outcome of the replacement is the initiation of 
 6 
functional changes in the proteins containing L-canavanine. Thus the anti-metabolic properties of L-




Figure 1.1 Chemical structure of D-pinitol (Do et al., 2008). 
 
D-pinitol (Figure 1.1) is a legumous chiro-inositol sugar found at levels of 14mg per gram of dry SF 
leaf (Moshe, 1998; van Wyk and Albrecht, 2008). D-pinitol possesses anti-diabetic properties (Bates et 
al., 2000) and has been implicated in treating wasting in cancer and acquired immunodeficiency 
syndrome (AIDS) (Ostlund and Sherman, 1996).  This insulin-like effect makes glucose readily 
available to cells for increased metabolism, thus increasing intracellular ATP levels.  Pro-inflammatory 
cytokines such as tumour necrosis factor alpha (TNF-α) and interleukin one beta (IL-1β) was reduced 
in rats with acute oedema treated with D-pinitol (Sia, 2004).    
 
1.1.6 Gamma amino butyric acid 
In SF tablets there is more or less 0.4mg/g of GABA (Tai et al., 2004). Gamma amino butyric acid is 
an inhibitory neurotransmitter which mediates its effects outside the nervous system (van Wyk, 2008). 





Figure 1.2 The relationship of GABA to pathways in metabolism     
   (Shelp et al., 1999).   
 
In general, GABA was found to affect the absorption of ions in the renal tubules (Parducz et al., 1992). 
Intracellularly, GABA is shunted along enzymes, glutamate decarboxylate (GAD), GABA 
transaminase (GABA-T) and succinic semialdehyde dehydrogenase to form intermediates that can 
enter the Kreb’s cycle (Figure 1.2).  
 
1.1.7 Sutherlandia frutescens tablets 
Phyto Nova SutherlandiaTM Tablets are readily available as an over the counter complementary 
medicine. It is suggested that one tablet be taken twice a day after meals. Each tablet contains 300mg 
milled select SF subspecies microphylla chemotype. Side effects that have been documented include 
observed dizziness, loose stool, mild constipation and dry mouth (Mills et al., 2005).  
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1.1.8 Pharmacology of Sutherlandia frutescens 
1.1.8.1 Stress 
Stress is often associated with increases in circulating levels of steroid hormone. Sutherlandia 
frutescens is believed to have stress alleviating properties. This facet of SF was elucidated in a study 
by Prevoo et al. (2008) where experimental results indicated the attenuation of adrenal cytochrome 
P450 enzymes, CYP17 and CYP21. These enzymes are actively involved in the biosynthesis of steroid 
hormones. The potential for SF to depress the activity of these enzymes provide insights to the 
mechanism behind the stress-relieving effects observed (Prevoo et al., 2008). 
 
1.1.8.2 Epilepsy 
Many experiments are currently being conducted to determine the mechanism by which SF exerts its 
biological effect/s in cells. In an in vivo experiment, SF (50-400 mg/kg i.p) was found to possess 
significant anticonvulsant and antiseizure effects in Balb/C mice following epilepsy induction by 
pentylenetetrazole (Ojewole, 2008).    
 
1.1.8.3 Antioxidant properties 
Luminal and lucigenin enhanced chemiluminescence was used to investigate the hydroxyl free radical 
and superoxide scavenging properties of an aqueous extract of SF. This study revealed that SF 
displayed anti-oxidant potential with concentrations as low as 10µg/ml in cell free and stimulated 
neutrophil systems (Fernandes et al. 2004).  
 
In another study by Tai et al. (2004) the antioxidant capacity of a 70% ethanolic extract of SF was 
determined. This study showed that 0.5µl of the ethanolic SF extract was comparable with 10µM of 
Trolox, an effective chemical with antioxidant activity. 
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1.1.8.5 Anti-inflammatory properties 
During inflammation a vast array of factors are released and synthesised. One of these factors is the 
enzyme, cyclooxygenase (COX-2) which is involved in prostaglandin (PG) synthesis and 
inflammation. A study by Kundu et al. (2005) on the inflammatory properties of a methanolic extract 
of SF showed an inhibition of COX-2 induction in vitro and in vivo. In this study, tumour promoter 12-
O-tetradecanoylphorbol-13-acetate was applied on mice skin followed by SF. The expression of 
cyclooxygenase-2 was found to be suppressed by 26% and 48% in mice treated with 100mg and 
200mg of the SF extract, respectively. 
 
1.1.8.6 Antiviral activity 
The resort for primary health care for many HIV+ individuals in South Africa is traditional herbal 
therapy as it is often difficult to access proper health care facilities (Mills et al., 2005). In 2005 Harnett 
et al. reported that HIV+ individuals who consumed SF showed an improvement in their mood, 
appetite, weight gain, cluster differentiation 4 positive (CD4+) counts as well as decreased viral loads.  
It is thought that the antiretroviral activity of SF is through inhibition of HIV-1 target enzymes, such as 
HIV-1 reverse transcriptase (Harnett et al., 2005).  
 
1.1.8.7 Diabetes 
A recent study showed that SF had hypoglycaemic properties and was useful in the treatment of type II 
diabetes.  In this study crushed SF leaves in drinking water was administered to Wistar rats fed a high 
fat diet. The results showed that SF was an efficient hypoglycaemic mediator in comparison to 
metformin (the commonly used anti-diabetic drug) (Chadwick et al., 2007). 
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The hypoglycaemic effect of SF was also demonstrated in streptozotocin (STZ)-induced diabetic rats 
(Type I diabetes) (Ojewole, 2004). This study found that SF caused significant hypoglycaemia in the 
STZ-treated rats when dosed with concentrations of 50-800mg/kg i.p. of the extract. 
 
1.1.8.8 Apoptotic properties of Sutherlandia frutescens 
The SF plant is commonly referred to as the ‘cancer bush’ and is used by traditional healers to treat 
cancer. To determine whether SF possessed anti-cancer properties, human breast adenocarcinoma cells 
were exposed to an ethanolic extract of SF. The results showed morphological characteristics of 
apoptosis and cell growth inhibition by affecting the mitogen activated protein kinase pathway 
(Stander et al., 2007, Stander et al., 2009).  
 
The antiproliferative effect of SF was also demonstrated to be concentration dependant in breast 
cancer, the promyelocyte cell line HL60 and leukemia Jurkat cell line (Tai et al., 2004).  
 
A separate study by Chinkwo (2005) demonstrated the apoptotic properties of SF on Caski cells 
(cervical carcinoma), Chinese hamster ovary (CHO) and Jurkat T lymphoma cell line. The classical 
hallmarks of apoptosis such as cell shrinkage, breakdown and a decrease in cell numbers, was noted. 
This study used the apoPercentageTM assay and Crossmon Trichrome stain which detects 
phosphatidylserine externalisation and chromatin condensation, respectively. Jurkat T cells treated 
with 3.5 mg/ml SF for 6 and 24 h were analysed by Annexin-V staining and flow cytometry showed 
approximately 84% apoptotic cells (Chinkwo, 2005).  
 
Ethanolic extracts of SF was used to determine the apoptotic effects on the MCF-7 human breast 
carcinoma cell line (Stander et al., 2007). Microscopical analysis showed that SF treated cells 
displayed altered morphology. The changes included cytoplasmic shrinking, membrane blebbing and 
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apoptotic bodies - representing the classical characteristics of apoptosis. Changes in the expression of 
345 genes in cells treated with SF were found using cDNA microarray analysis. Changes have been 
noted in genes which code for proteins involved in apoptosis, cell cycle regulation and signal 
transduction. These include TNF superfamily members 10a and 10b, caspase recruitment domain 
family, member11 amongst others (Stander et al., 2007). 
 
1.2 The Nephron 
1.2.1 Function of the Nephron 
The route of elimination of polar compounds from the circulation occurs via the renal system. The 
kidney receives between 20% – 25% of the total cardiac output and therefore any substance in the 
systemic circulation reaches the kidney in large quantities. The functional unit of the kidney is the 
nephron. The kidney functions to filter blood, allowing substances to enter the Bowman’s capsule and 
renal tubules. Filtered nutrients are actively reabsorbed at the proximal convoluted tubule (PCT) and 
ions are actively reabsorbed at the distal convoluted tubule (DCT) (Klaassen, 2000). The proximal and 
distal tubules, based on their functions, have different cell architectures (Young et al., 2000).  
 
1.2.2 Structure of the Nephron 
The PCT epithelium (simple cuboidal epithelium) has a brush border of tall microvilli that extends into 
the lumen. This functions to increase the surface area 20-fold for the efficient reabsorption of 
molecules from the glomerular filtrate back into circulation.  
Histologically, PCT cells stain intensely due to the high content of organelles and mitochondria. The 
PCT is responsible for the active reabsorption of approximately 100% of glucose and amino acids 
from the glomerular filtrate (Young et al., 2000). The DCT cells are smaller simple cuboidal epithelial 
cells that stain less intensely due to the presence of fewer organelles. The DCT is involved in the 
active reabsorption of sodium from the tubular fluid and lacks a brush border (Young et al., 2000).   
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The close proximity of filtered substances to the renal tubular epithelium and the ability of the kidney 
to concentrate toxicants increase the susceptibility of these cells to damage. 
 
1.3 Biochemical Activity of PCT and DCT Epithelial Cells 
1.3.1 Energy Generation  
The mitochondrion is considered the energy generator of all aerobic eukaryotic cells. This organelle is 
responsible for production of most of the energy, signalisation, biosynthesis and apoptotic mechanisms 
(Saraste et al., 1999). The control of and the manner in which these cellular mechanisms occur plays a 
determinant role in cell physiology. The differences in energy utilisation lie not only between organs 
but are highly specific to the functionality of each cell type. Hence, the number and activity of 
organelles such as mitochondria in the proximal and distal convoluted tubular epithelial cells are 
different.  
 
A distinctive feature of the mitochondria is the presence of a double membrane system, the inner and 
outer membranes. The outer membrane is not a significant permeability barrier as it contains 
transmembrane channel proteins (porins). The inner membrane is extremely convoluted forming 
cristae to increase the surface area and it presents a permeability barrier to most solutes. The inner 
mitochondrial membrane has transport proteins and protein complexes involved in electron transport 
and ATP synthesis.  The high surface area provided by the cristae enhances the capacity of ATP 
production (Mathews et al., 2000).  
 
Energy generation by the mitochondria occurs primarily through oxidative phosphorylation. This is a 
process by which electrons are passed along a series of carrier molecules in the electron transport chain 
(ETC). These electrons are attained from the oxidation of reduced nicotinamide adenine dinucleotide 
(NADH) and flavin-adenine dinucleotide dihydrogen (FADH2) which are produced during glycolysis, 
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Kreb’s cycle and other oxidation reactions during the metabolism of nutrients. Five enzyme complexes 
make up the ETC, complexes I, II, III and IV transport electrons and complex V catalyses the synthesis 
of ATP. These complexes function to accept electrons from electron carriers and transfer them to the 
next carrier in the chain. The electrons, ultimately, combine with protons and oxygen to produce water 
(Mathews et al., 2000).  
 
Complex I (NADH: ubiquinone oxidoreductase) receives the free proton from NADH and transfers it 
to flavin mononucleotide (FMN) producing reduced FMNH. Succinate: ubiquinone reductase (Figure 
1.3) is also known as complex II which transfers electrons from succinate to flavin-adenine 
dinucleotide (FAD). Electrons from complexes I and II are then accepted by coenzyme Q which 
transports these electrons to complex III.  
 
Complex III is responsible for the deliverance of electrons from coenzyme Q to cytochrome C in a 
redox reaction coupled by the generation of a proton gradient across the membrane. Cytochrome 
oxidase (complex IV) also generates a proton gradient against the transmembrane by receiving 
electrons from cytochrome c in its active site with haem iron and copper.  
 
The active site of complex IV has a haem iron and a copper molecule that is uses to reduce oxygen into 
two water molecules utilising two protons from the mitochondrial matrix simultaneously pumping a 

















Figure 1.3 The transmembrane proteins of the inner mitochondrial matrix that are  
   involved in the electron transport chain and oxidative phosphorylation.  
   Complex I (NADH-DH), Complex II (SDH), Complex III (bc1), Complex IV  
   (COX) transfers electrons to oxygen. Complex I, III IV translocate protons  
   across the membrane creating a proton gradient that Complex V(ATP  
   synthase) uses to synthesise ATP (adapted from Mathews, 2000). 
 
Mitochondrial ATP synthase (Complex V) synthesises ATP from ADP and Pi, using a proton motive 
force across the membrane and it can hydrolyse ATP to pump protons against an electrochemical 
gradient. It is made up of two major complexes (F1 and F0). The F0 complex is embedded within the 





1.3.2 Free Radicals  
Any molecule that is capable of independent existence when it contains one or more unpaired electrons 
is regarded as a ‘free radical’. This class of molecules include superoxide (O2.-), hydroxyl (OH.), thiyl 
(RS.), trichloromethyl (CCl3.) and nitric oxide (NO.) (Halliwell and Chirico, 1993; Jones, 2006).  
 
The oxygen-centred radicals are considered the most important in vivo generated free radicals. These 
reactive oxygen species (ROS) arise as a result of normal metabolic processes as well as physical 
irradiation. NADPH oxidase is responsible for the production of ROS in inflammatory cells during 
cell-mediated immunity and antimicrobial activity. The production of ROS by reduced nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase in non-inflammatory cells is used for cell 
signalling. Superoxide generation in eukaryotic aerobic cells occurs in abundance at the mitochondrial 
ETC during the synthesis of ATP (Cadenas and Sies, 1998).  
 
Cytochrome oxidase, complex IV in the ETC, contains haem iron and copper which transfers one 
electron at a time to oxygen. This process is not efficient and therefore allows for the generation of 
incompletely reduced oxygen species (Jones, 2006). Depending on the number of electron reductions 
of oxygen different ROS are formed. A single electron reduction produces superoxide, two electron 
reductions produces hydrogen peroxide (H2O2) and three-electron reduction produces the hydroxyl 
radical (OH.) (Halliwell and Chirico, 1993).  
 
The OH., most reactive of the ROS, has a half life of 10-9s and is responsible for the damage of 
biological molecules such as cellular lipids, proteins, and DNA (Pastor et al., 2000). Polynucleotide 
strand breakage, double stranded DNA breaks, base alterations and nucleotide base lesions occur as a 
result of OH. damage (Mathews et al., 2000). Superoxide radicals and H2O2 may not be as detrimental 
as OH., however O2. readily reacts with NO to form peroxynitrite (OONO-) (Klatt & Lamas, 2000; 
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Ridnour et al., 2004). This reactive nitrogen species causes lipid peroxidation and protein damage by 
nitration of tyrosyl hydroxyl groups (Mathews et al., 2000).  
 
The cell attempts to dissipate the superoxide radical by converting it to H2O2, a reaction catalysed by 
superoxide dismutase. Hydrogen peroxide, however, reacts with transition metals, iron and copper, 
during the Fenton reaction giving rise to highly reactive OH.. The OH. is then free to react with 
polyunsaturated fatty acids (PUFA) to produce a carbon-centred lipid radical (Halliwell and Chirico, 
1993). The lipid radical can then react with iron resulting in lipid alkoxyl radicals or with O2.- forming 
lipid peroxyl radicals.  
 
Lipid peroxidation is initiated when these reactive lipid peroxyl radicals are not detoxified by cellular 
antioxidants. The lipid alkoxyl radical undergoes cyclisation forming an intermediate product which 
can degrade into malondialdehyde (MDA). Nucleotide bases, cytosine, adenine and guanine, of DNA 
are targets of MDA which result in the formation of DNA adducts (Halliwell and Chirico, 1993).  
 
1.3.3 Antioxidants 
Oxidative stress is dealt with in vivo by both enzymatic and non-enzymatic antioxidant systems. The 
enzymatic antioxidant mechanisms include superoxide dismutase (SOD) and peroxidases. The non-
enzymatic antioxidant system includes molecules such as vitamin C, vitamin E, beta-carotene, 
flavonoids, glutathione (GSH) and uric acid (Mathews et al., 2000).  
 
Superoxide dismutase is a metalloenzyme that catalyses the dismutation of two O2.- molecules to H2O2 
and O2. Peroxidases include catalase and GSH peroxidase. Catalase reduces H2O2 to water and O2, and 
GSH peroxidase reduces H2O2 to water along with the oxidation of GSH (Mathews et al., 2000).  
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Vitamin C (ascorbic acid) is a major extracellular antioxidant but is also capable of scavenging 
radicals in the aqueous phases of the cytoplasm. Vitamin E and beta-carotene act as antioxidants in 
hydrophobic environments (Mathews et al., 2000). Both vitamin C and vitamin E detoxify 
intermediates formed during lipid peroxidation. The lipid peroxyl radical is acted upon in the 
membrane by the reduced form of vitamin E forming lipid hydro-peroxide and a vitamin E radical. 
Vitamin C then regenerates vitamin E by accepting the free radical and forming an ascorbyl radical. 
The vitamin E radical can also be reduced by GSH. The oxidised GSH and ascorbyl radical are 
subsequently reduced to GSH and ascorbate monoanion by dihydrolipoic acid (DHLA) which is then 
converted to alpha-lipoic acid (ALA). Dihydrolipoic acid is regenerated from ALA using NADPH 
(Mathews et al., 2000).  
 
Glutathione (Figure 1.4), also called gamma-glutamylcysteinylglycine, is a tripeptide that is present in 
most cells (Sies, 1999). This molecule is responsible for protecting the cell against oxidative stress. 
This is accomplished by acting as a cofactor for detoxification enzymes, scavenging hydroxyl radicals 
and singlet O2, detoxifying H2O2 and lipid peroxides. GSH also plays a role in the regeneration of 
vitamin C and vitamin E as mentioned previously.  
 
 
Figure 1.4 Structure of glutathione (Sies, 1999). 
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An important feature of GSH is the presence of a free thiol group with which it forms conjugates with 
a range of electrophilic compounds nonenzymatically, or through the action of GSH–S-transferase 
(Sies, 1999). The resulting GSH-conjugates are removed by the biliary system. They may also be 
metabolised further by hydrolysis and N-acetylation reactions resulting in mercapturic acid which is 
excreted by the renal system (Dickinson and Forman, 2002).  
 
The reduction of peroxides by GSH peroxidase produces oxidised glutathione (GSSG).  The depletion 
of GSH is circumvented by GSH reductase catalysing the reduction of GSSG to GSH using NADPH. 
During oxidative stress the level of transcription of GSH peroxidase is up-regulated and the rate of 
post-translational modification is increased. Aberrant expression of this enzyme and its activity has 
been associated with many pathologies including hepatitis (Downey et al., 1998), HIV (Banki et al., 
1998) and cancers of various tissues including the kidney (Okamoto et al., 1994).  
 
1.3.4 Cells Response to Stress 
Cell signalling and signal transduction are the two means by which cells communicate with each other 
(Poli et al., 2004). Extracellular signals such as hormones, cytokines, growth factors and 
neurotransmitters trigger signal transduction and allow information to be transferred from the outside 
to the intracellular elements (Thannickal and Fanburg, 2000). When a cell is placed under stress due to 
heat shock or xenobiotics, for example, several signalling cascades are activated to enhance cell repair 
mechanisms and promote cell survival.  
 
1.4  The Fate of the Cell 
Cells that are unable to recover from oxidative stress and chemical damage are signalled to undergo 
cell death. Cell death may occur either through necrosis or apoptosis. Necrosis usually occurs in cells 
following acute tissue injury and results in the release of intracellular molecules into the extracellular 
 19 
matrix, initiating an inflammatory response. Tissue homeostasis and the demise of individually 
affected cells occur via programmed cell death/ apoptosis.  
 
 1.4.1 Apoptosis 
A variety of mechanisms can induce apoptosis in cells. Intracellular pro- and anti-apoptotic factors, the 
severity of the stimulus and the stage of the cell cycle determine whether the signalled cell will 
undergo apoptosis or not. Apoptosis can be stimulated by extracellular or intracellular signals.  
 
Extrinsic signals include binding of death inducing ligands (from the surface of other cells or soluble 
factors) to death receptors. Intrinsic apoptotic signals are produced following exposure to radiation, 
viral infection, growth factor deprivation or oxidative stress (Figure 1.5) (Hengartner, 2000). 
 
1.4.1.1    Extrinsic Apoptotic Activation 
Fas, tumour necrosis factor receptor 1 (TNFR1) and tumour necrosis factor related apoptosis inducing 
ligand (TRAIL), death receptor 4 and death receptor 5 are the best characterised and understood 
extrinsic death receptors which belong to the TNF-α superfamily. 
 
The interaction of TNF-α with TNFR1 causes receptor trimerisation and the clustering of intracellular 
death domains (Van Antwerp et al., 1998). This allows intracellular TNFR1-associated death domain 
(TRADD) to bind to the death domain followed by the recruitment of TNF-associated factor 2 
(TRAF2) to the death receptor. The NF-kB and the Jun NH2-terminal kinase (JNK)/Ap-1 pathway are 
then activated by TRAF2. 
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Figure 1.5 Programmed cell death – extrinsic and intrinsic activation    
   (Hengartner, 2000). 
 
The TNFR1 also recruits receptor-interacting protein (RIP)-associated ICH-1 homologous protein with 
death domain which uses caspase recruitment domain to recruit caspase 2. Fas associated death 
domain (FADD) interaction with TRADD also induces apoptosis by the recruitment and cleavage of 
procaspase 8 using its death effector domain (DED) (Ashe and Berry, 2003).  
 
The death inducing signalling complex (DISC), formed by the interaction of procaspase 8 with the 
DED of FADD, is a multi-protein complex and is responsible for the fate of the cell as its composition 
activates either apoptotic or survival pathways. The apoptotic pathway can occur rapidly by the 
recruitment of a high number of caspase 8 to DISC, or slowly with few caspase 8 molecules recruited 
and slow initiation of apoptosis following the involvement of the mitochondrial apoptotic pathway.  
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Caspase 8 cleaves downstream caspase 3 as well as pro-apoptotic molecule Bid to truncated Bid 
(tBid). Second mitochondrial activator of caspases (Smac)/Diablo, apoptosis inducing factor (AIF), 
cytochrome c, and endonuclease G are mitochondrial factors whose release is stimulated by truncated 
bid (tBid) (Ashe and Berry, 2003). 
 
1.4.1.2 Intrinsic pathway of activation for apoptosis 
As described by Chowdhury et al. (2008), a range of factors including cell stress, oxidative stress, heat 
shock and DNA damage can lead to the intrinsic activation of apoptosis. The mitochondrion is an 
important organelle in the process of apoptosis as the mitochondrial membrane is the site at which 
anti-apoptotic proteins B cell CLL/lymphoma 2 (Bcl-2) and Bcl-X are located.  
 
Pro-apoptotic molecules such as cytochrome c is located within the mitochondria and pro-apoptotic 
protein Bax and Bad mediate apoptosis by interacting directly with the mitochondrial membrane or 
with mitochondrial associates Bcl-2 and Bcl-X (Gross et al., 1998, Lalier et al., 2007). Bax is thought 
to have the ability of forming pores in the mitochondrial membrane thereby promoting the release of 
cytochrome C and AIF (Lalier et al., 2007). The release of cytochrome c, which may also be caused by 
cell stress, involved in apoptotic activation makes it available to form an apoptosome with apoptotic 
protease activating factor-1 (Apaf-1) and caspase 9 (Yang et al., 1997).  
 
Damage to cellular DNA and protein leads to the generation of pro-apoptotic molecules such as Bax 
following the activation of p53 (Figure 1.5). The p53 protein, also known as the tumour suppressor 
protein, has been associated with key responses of the cell to DNA damage (Haffner and Oren, 1995). 
The p53 protein plays an integral role in monitoring cellular stress and inducing apoptosis, when 
required (Hosfseth et al., 2004). The maintenance of appropriate levels of p53 is accomplished by 
mouse double minute 2 (Mdm2). This enzyme binds to the p53 protein and promotes its 
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polyubiquinitation and degradation, therefore maintaining low intracellular levels of this protein 
(Brooks and Gu, 2003).  
 
Changes in chromatin structure are a consequence of DNA damage. This phenomenon leads to 
activation of the chromatin-bound protein kinase, ataxia telangiectasia mutated protein (ATM), ATM 
related (ATR) and DNA-dependant protein kinase (DNA-PK) proteins which then phosphorylates p53 
(Hickman et al., 2002; Kubbutat and Vousden, 1998). Activated p53 accumulates in the nucleus and 
binds to DNA sequences and induces transcription of proapoptotic proteins. p53 acts as a promoter of 
apoptosis by suppressing anti-apoptotic protein gene expression, Bcl-2, Bcl-xL (Yu and Zhang, 2005) 
and cFLIP (Ashe and Berry, 2003).  
 
1.4.1.3 Caspases – Effectors of Apoptosis 
The caspases, a group of cysteine proteases, are effectors of apoptosis that are present in cells in an 
inactive form. Stimuli that promote apoptosis initiate the cleavage of the procaspases thereby initiating 
the caspase cascade for the execution of apoptosis. The binding of appropriate ligands to death 
receptors activates the initiator caspases 10 and 8. These activate downstream caspases in the caspase 
cascade until the effector caspases 3, 6 and 7 are activated. The targets of effector caspases include 
nuclear lamins, ICAD/DNA fragmentation factor 45, PARP-1 and P 21- activated kinase 2 that result 
in morphological features of apoptotic cells (Kerr et al., 1972). 
 
The intrinsic pathway of apoptosis ultimately results in the activation of executioner caspase 3 as well. 
Release of cytochrome c from the mitochondria occurs in concert with Smac/DIABLO. The formation 
of the apoptosome with cytochrome c, apaf-1 and procaspase 9 renders caspase 9 active. The presence 
of inhibitors of apoptosis proteins (IAP’s) is able to react with caspase 9 and prevent further activation 
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of the caspase cascade. The release of Smac/DIABLO allows it to bind to IAP’s thereby allowing 
caspase 9 to cleave and activate caspase 3 (Ekert et al., 2001).   
 
The features of apoptosis are DNA fragmentation by endogenous nucleases that are activated by 
effector caspases, cytoplasmic shrinkage due to the cleavage of lamins and actin filaments, chromatin 
condensation due to the degradation of nuclear structural proteins, externalisation of 
phosphatidylserine on the membrane of cells to promote phagocytosis, membrane blebbing and the 
formation of apoptotic bodies. This process is intricate and involves several protein families, sub 
cellular compartments and signal transduction cascades (Hengartner, 2000).  
 
The availability, utilisation and popularity of medicinal plants are increasing amongst the South 
African communities. Scientific evidence that supports the effectiveness of herbal therapies such as SF 
is emerging, proving its antiviral, antioxidant, antiproliferative and hypoglycaemic properties. 
Naturally, traditional therapeutics is accepted by the populous; however, continued research by in 












SCIENTIFIC PAPER PUBLICATION 
PREFACE 
 
The following paper has been published in the South African Journal of Science, Volume 106, Article 
#10, Pages 54 - 58, documents the effect of Sutherlandia frutescens on cultured renal epithelial cells.  
 This study was undertaken in light of the lack of literature regarding the therapeutic value and 

























CHAPTER 3  
CONCLUSION 
 
Sutherlandia frutescens is one of approximately 3 000 medicinal plants that is utilised daily to treat a 
wide range of illnesses in our population. These plants are now commercially available and their 
therapeutic potential remains to be elucidated. Continuous research into the safety and efficacy of the 
medicinal plant, SF, for human ailments need to be intensified. 
 
The conclusions drawn from the current study indicate that SF is not cytotoxic to renal tubule 
epithelial cells at low concentrations. The plant extract at higher concentrations, however, induces cell 
death via apoptosis in renal tubule epithelia.  Also, high concentrations of SF water extracts increased 
oxidative stress and altered the integrity of the mitochondrial membrane.   
 
This in vitro experiment provides evidence that SF, if consumed moderately, may in essence; prove to 
be a safe therapeutic. Further research such as clinical trials are required to prove the safety and 
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ABSTRACT
Sutherlandia frutescens (SF), a medicinal plant indigenous to South Africa, is traditionally used to 
treat a diverse range of illnesses, including cancer and viral infections. The biologically active 
compounds of SF are polar, thus renal elimination increases susceptibility to toxicity in that organ. 
This study investigated the antioxidant potential, lipid peroxidation, mitochondrial membrane 
potential and apoptotic induction by SF extracts on proximal and distal tubule epithelial cells. 
Cell viability was determined using the MTT assay. Mitochondrial membrane potential was 
determined using a flow cytometric JC-1 Mitoscreen assay. Cellular glutathione and apoptosis 
were measured using the GSH-Glo™ Glutathione assay and Caspase-Glo® 3/7 assay, respectively. 
The IC50 values from the cell viability results for LLC-PK1 and MDBK were 15 mg/mL and 7 
mg/mL, respectively. SF extracts significantly decreased intracellular glutathione in LLC-PK1 
(p < 0.0001) and MDBK (p < 0.0001) cells, while lipid peroxidation increased in treated LLC-
PK1 (p < 0.0001) and MDBK (p < 0.0001) cells. JC-1 analysis showed that SF extracts promoted 
mitochondrial membrane depolarization in both LLC-PK1 and MDBK cells by up to 80% 
(p < 0.0001). The activity of caspase 3/7 increased in both LLC-PK1 (11.9-fold; p < 0.0001) and MDBK 
(2.2-fold; p < 0.0001) cells. SF extracts at high concentrations appear to increase oxidative stress, to 
alter mitochondrial membrane integrity, and to promote apoptosis in renal tubule epithelia. 
INTRODUCTION
Sutherlandia frutescens (SF), a member of the Leguminosae family, is a multipurpose medicinal plant 
endemic to South Africa.1 Commonly known as ‘cancer bush’, it has been used in crude form for years 
by traditional healers to treat a variety of ailments including internal cancers, diabetes, uterine disease, 
influenza, HIV, depression, and arthritis. 1 Various doses of SF leaf powder have been administered to 
humans, but have produced no known side effects. 
Leaves of SF contain the biologically active compounds L-canavanine, D-pinitol, gamma amino butyric 
acid (GABA), parabens, saponins, cycloartane glycosides and triterpenoid diglucoside.2,3,4 L-canavanine 
stores nitrogen in seeds and is used in plant chemical defense mechanisms.5,6 Its production by 
SF is dependent on the availability of abiotic factors.7 L-canavinine, a non-protein amino acid, is a 
structural analogue of L-arginine. It can be recognised by arginine-utilising enzymes such as arginyl-
tRNA synthetase, and consequently can be incorporated into newly synthesised peptides.5 Canaline, 
produced by arginase-mediated hydrolytic cleavage of L-canavanine, has been shown to have anti-
tumour properties.8 D-pinitol, a chiro-inositol sugar, possesses anti-diabetic properties and is used in 
the treatment of wasting in cancer and HIV/AIDS patients.9,10 
GABA, an inhibitory neurotransmitter, mediates most of its effects inside the nervous system.11 It has 
been used as a drug for the relief of anxiety and stress.12 Interestingly, GABA has been shown to affect 
the absorption of ions in the renal tubules.13 Intracellularly, GABA is metabolised through the action of 
the enzymes glutamate decarboxylase, GABA transaminase and succinic semialdehyde dehydrogenase, 
and is transformed into citric acid cycle intermediates.14 
Many experiments have been done to determine the mechanism(s) of action of SF extracts. In an in 
vivo experiment it was concluded that SF extracts possessed anticonvulsant effects in mice subjected 
to the induction of epilepsy.15 SF-treated human breast adenocarcinoma cells in culture showed 
morphological characteristics of apoptosis and cell growth inhibition.16,17 An antiproliferative effect of 
SF was demonstrated to be concentration-dependent in breast cancer and leukaemia cell lines, with no 
significant antioxidant effects.2 Another study, by contrast, showed that SF extracts displayed antioxidant 
potential (hydroxyl free radical and superoxide scavenging properties) in cell-free and stimulated 
neutrophil systems.18 An apparent antiretroviral activity of SF has been thought to be mediated by the 
inhibition of HIV-1 target enzymes, such as HIV-1 reverse transcriptase.19 
The route of elimination of polar compounds from the circulation occurs via the renal system. The 
kidney functions to filter blood, allowing substances to enter Bowman’s capsule and the renal tubules. 
Filtered nutrients are actively reabsorbed at the proximal convoluted tubule (PCT), while ions are 
actively reabsorbed at the distal convoluted tubule (DCT).20 Based on their contrasting functions, the 
PCT and DCT epithelia have different cell architectures.21
The PCT epithelium has a brush border of tall microvilli that extends into the lumen to increase the 
surface area 20-fold for the efficient reabsorption of molecules from the glomerular filtrate back into 
circulation. Histologically, PCT cells stain intensely with eosin due to their high content of organelles 
and mitochondria. The PCT is responsible for the active reabsorption of 99% of glucose and amino 
acids from the glomerular filtrate.21 The DCT cells are smaller, simple cuboidal epithelial cells (stain 
less intensely due to fewer organelles) that actively reabsorb sodium from the tubular fluid.21 The close 
proximity of filtered substances to this kind of tubular epithelium increases the susceptibility of these 
cells to damage.
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To date, limited scientific evidence has been available on the 
mechanism by which SF extracts affect cellular processes and the 
side effects related to their use. This medicinal plant, however, 
continues to be recommended as a traditional remedy and is 
used by a large portion of the South African community. In 
this study, the nephrotoxic and apoptotic effects of SF extracts 
on two kidney cell lines, LLC-PK1 (PCT epithelium) and MDBK 
(DCT epithelium), were investigated and compared. 
MATERIALS AND METHODS
Materials
Sutherlandia frutescens tablets (Phyto NovaTM, Cape Town, South 
Africa) were purchased from a local pharmacy. The LLC-PK1 
and MDBK cell lines were purchased from Highveld Biologicals 
(Johannesburg, South Africa). All tissue culture reagents, the 
GSH-GloTM Glutathione Assay and the Caspase-Glo® 3/7 Assay 
were obtained from Whitehead Scientific (Johannesburg, South 
Africa). The JC-1 dye was purchased from BD Biosciences (South 
Africa). All other reagents were purchased from Merck (South 
Africa) unless otherwise stated.
Preparation of Sutherlandia frutescens extracts
Phyto Nova SutherlandiaTM tablets were used to prepare an 
aqueous extract of the active ingredients of the plant. Sixty 
tablets were crushed to a fine powder in a pestle and mortar, 
weighed and suspended in deionised water (1.2 g per 10 mL). 
The mixture was continuously stirred at room temperature for 
1.5 h, and thereafter transferred to 50 mL sterilin tubes and 
centrifuged (3 645 g, 10 min) at room temperature. The upper 
aqueous layer (SF extract) was removed, vacuum filtered and 
stored at 4 °C. SF extract dilutions (24 mg/mL, 12 mg/mL, 6 
mg/mL, 2.4 mg/mL, 1.2 mg/mL, 0.6 mg/mL, and 0.3 mg/mL) 
were prepared using complete culture media (CCM), comprising 
Eagle’s minimum essential medium, 10% foetal calf serum, 1% 
L-glutamine and 1% penstrepfungizone. 
  
Cell culture and cytotoxicity assay
LLC-PK1 and MDBK cells were cultured (37 °C, 5% CO2) to 
confluency in 75 cm3 flasks in CCM. The cytotoxicity of SF in 
LLC-PK1 and MDBK cells was measured using the MTT assay.
22 
LLC-PK1 and MDBK cells (10 000/well) were incubated with 
varying SF extract dilutions for 48 h in triplicate in microtitre 
plates, together with the respective controls (cells incubated 
with CCM only). The cells were then incubated with the MTT 
substrate (5 mg/mL) for 4 h. Thereafter all supernatants were 
aspirated, and dimethyl sulphoxide (DMSO) (100 µL/well) was 
added to the wells. Finally, the optical density was measured at 
570 nm, with a reference wavelength of 690 nm, by an enzyme-
linked immunosorbent assay (ELISA) plate reader (Bio-Tek 
µQuant). The data were translated to ‘percentage cell viability’ 
versus ‘concentration of extract’, from which the IC50 (half the 
maximal inhibitory concentration) values for each cell line and 
for the combination of treatments were determined. For all 
subsequent biochemical assays, both cell lines were grown to 
confluency and treated with the determined IC50 values of the 
SF extracts. 
Lipid peroxidation assay
Oxidative damage of both cell lines was assessed using 
the thiobarbituric acid assay, because lipid peroxidation is 
commonly quantified by levels of malondialdehyde (MDA). 
After the 48 h incubation with SF extract, the culture fluid from 
each SF-treated flask and from the untreated controls (500 µL) 
was dispensed into duplicate glass tubes (one representing 
the sample, one representing a negative control), followed by 
addition of 7% H2PO3 (200 µL). A positive control of 1% MDA 
was prepared. Thiobarbituric acid (1%, w/v)/ 0.1 mM butylated 
hydroxytoluene solution (400 µL) was added to sample tubes. 
To the tubes with the negative controls, 400 µL of 3 mM HCl 
was added. The solution was adjusted to pH 1.5 and heated at 
100 ○C for 15 min. Once cooled, butanol (1.5 mL) was added 
and the sample then centrifuged (8 400 g, 6 min). Following 
centrifugation, the butanol phase (200 µL) from each sample and 
from the blanks was aliquoted into a microtitre plate. The optical 
density was measured at 532 nm, with a reference wavelength 
of 600 nm, by an ELISA plate reader. The sample means of 
ten replicates were calculated and divided by the absorption 
coefficient, 156 mM-1. 
Glutathione assay
The GSH-GloTM Glutathione Assay (Promega, Madison, USA) 
was used to measure glutathione (GSH) levels. Cells (those 
treated with SF extract and the untreated controls after 48 h 
incubation) were transferred to an opaque microtitre plate (50 
µL of 10 000 cells/well, 10 replicates). GSH standards (0 µM 
– 5 µM) were prepared from a 5 mM stock solution diluted in 
water. Five two-fold dilutions of the GSH stock were prepared 
and transferred into wells (50 µL) of the microtitre plate. 
The 2X GSH-GloTM Reagent was prepared according to the 
manufacturer’s instructions, added to the experimental wells 
(50 µL/well), and incubated at room temperature. Reconstituted 
Luciferin Detection Reagent (50 µL) was added to each well and 
incubated. The luminescence was measured on a ModulusTM 
microplate luminometer (Turner Biosystems, Sunnyvale, USA). 
A standard curve was derived using the GSH standards (0 
µM – 5 µM) and the GSH concentration in each sample was 
extrapolated from the equation. 
Caspase-3/7 assay
The apoptotic potential of SF extracts on both cell lines was 
determined using the Caspase-Glo®3/7 assay (Promega). 
Caspase-Glo®3/7 Reagent was reconstituted according to the 
manufacturer’s instructions and added to both the SF-treated 
and control cells (following 48 h incubation) in the wells of a 
microtitre plate (10 µL reagent per 50 µL of 10 000 cells/well, 10 
replicates) and incubated in the dark (30 min). The luminescence 
was measured on a ModulusTM microplate luminometer (Turner 
BioSystems). The caspase-3/7 activity of the SF-treated samples 
was represented as X-fold change compared to the control (cells 
incubated with CCM only). 
Mitochondrial membrane potential
The mitochondrial membrane potential (∆Ψm) of LLC-PK1 
and MDBK cells (both those treated with SF extract and their 
untreated controls; 48 h) was assessed using fluorescence-
activated cell sorting (FACS) and the JC-1 Mitoscreen assay 
(BD Biosciences) according to the manufacturer’s instructions. 
Cells (approximately 100 000) were transferred to polystyrene 
cytometry tubes. The JC-1 dye (150 µL) was added to the cells 
and allowed to incubate (37 °C, 5% CO2, 10 min). Cells were 
then washed with JC-1 Mitoscreen wash buffer (400 g, 5 min) 
and resuspended in 300 µL flow cytometry sheath fluid. Flow 
cytometry data from stained cells (15 000 events) was obtained 
using a FACSCalibur (BD Biosciences) flow cytometer with 
CellQuest PRO v4.02 software (BD Biosciences). Cells were 
gated to exclude debris using FlowJo v7.1 software (Tree Star 
Inc., Ashland, USA)
Statistical analysis
Results are expressed as the means, with error bars representing 
the standard deviations (s.d.) of the means. Statistical significance 
SF (mg/mL) LLC-PK1 CELL VIABILITY (%) MDBK CELL VIABILITY (%)
24 25 ± 0.0* 15 ± 0.3*
12 72 ± 2.1 24 ± 14.0*
6 89 ± 33.0 103 ± 12.7
2.4 107 ± 10.9 118 ± 3.7
1.2 103 ± 2.9 122 ± 9.3
0.6 122 ± 14.0 96 ± 7.9
0.3 133 ± 11.0 101 ± 10.3
TABLE 1
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FIGURE 1
 Basal GSH concentrations in LLC-PK1 and MDBK were different from each other
The levels of GSH were decreased significantly in LLC-PK1 cells treated with SF extracts (p < 
0.0001) compared with the relevant controls. The MDBK cells treated with SF also showed a decrease 
in GSH levels (p < 0.0001).  Results are presented as the mean ± s.d. and n = 10. (***p < 0.0001).
FIGURE 2
Levels of MDA in SF-treated cells 
The concentrations of MDA in LLC-PK1 cells (p < 0.0001) [A] and MDBK cells (p < 0.0001) [B] treated with SF were significantly higher than in their respective controls. Results are presented as the mean 
± s.d. and n = 10. (***p < 0.0001).
levels of lipid oxidation products in both SF-treated cell lines. 
There were significantly higher levels (p < 0.0001) of MDA in 
both the SF-treated cell lines as compared with the respective 
control cells (see Figures 2A and 2B).
Mitochondrial membrane potential analyses 
To determine whether LLC-PK1 and MDBK cells were 
metabolically viable after SF-extract treatment, we investigated 
changes in ∆Ψm. The SF-treated LLC-PK1 cells had a significantly 
higher (p < 0.0001) percentage of depolarised mitochondria as 
compared with the untreated cells (80.2% vs 54.6%) (see Figure 
3). Similarly, the MDBK cells had a significantly higher (p < 
0.0001) percentage of depolarised mitochondria as compared 
with controls (81.7% vs 58.2%) (see Figure 3). 
Caspase-3/7 assay
A significant change in ∆Ψm is a good indicator of apoptosis. 
The intracellular activities of caspase 3/7 in both SF-treated 
cell lines were measured (as a fold-change in comparison with 
the relevant controls). The activity of caspase 3/7 in SF-treated 
LLC-PK1 cells showed a highly significant 11.9-fold increase (p 
< 0.0001) compared with the controls. The SF-treated MDBK 
cells also showed a significant 2.2-fold increase (p < 0.0001) over 
controls (see Table 2). These results indicated that PCT cells were 
more susceptible to apoptotic induction by SF than were DCT 
cells.
DISCUSSION
SF is used by many South Africans as a traditional remedy 
or ameliorant for many diseases, including HIV infection. 
The crude plant concoction is normally taken orally and the 
main route of elimination of the absorbed constituent polar 
compounds is via the renal system. The potential for injury by 
noxious compounds in the PCT region is high due to the ability 
of the PCT cells to concentrate substances that have been filtered 
by the glomerulus.20 
The results of this investigation have shown that both kinds 
of renal tubular cells, LLC-PK1 and MDBK cells, are affected 
by SF extracts in vitro. This sensitivity may be attributed to 
the location and functional capacities of these cells. The intact 
PCT is susceptible to injury, as it is at this site of the nephron 
where toxicants accumulate and where there is an abundance 
of mitochondria for active re-absorption and transportation of 
ions, low molecular weight proteins, glutathione conjugates 
and heavy metals.20 Cells treated with SF extracts in vitro, at 
concentrations of 6 mg/mL and lower, displayed greater than 
89% viability. At such low concentrations, SF extracts appeared 
to promote cell metabolism as evidenced by the increased 
conversion of the MTT salt. This might have been due to both 
increased mitochondrial reductase enzyme activity,22 and 
increased availability of reducing equivalents such as NADH, 
between samples for the MTT assay was determined using the 
one-way ANOVA Tukey Kramer Multiple Comparisons test. 
The statistical significances of the lipid peroxidation assay, GSH 
assay, caspase-3/7 assay and mitochondrial depolarisation assay 
were determined by the Mann-Whitney test for non-parametric 




The cytotoxic effects of SF extracts (MTT assay) were determined 
in both LLC-PK1 and MDBK cells treated with a range of 
extract dilutions for 48 h (see Table 1). The IC50 for SF extract 
was determined as 15 mg/mL and 7 mg/mL dilutions for the 
LLC-PK1 and MDBK cells, respectively. The cell viability of both 
cell lines treated with concentrations between 6 mg/mL and 
0.3 mg/mL was more than 89%. However, at higher SF extract 
concentrations of 24 mg/mL and 12 mg/mL, respectively, cell 
viability was decreased to 25% and 72% of controls (p < 0.001) 
in the case of LLC-PK1 cells, and to 15% and 24% (p < 0.001) of 
controls in the case of MDBK cells. 
GSH assays
The intracellular concentrations of GSH in both SF-extract-
treated renal epithelial cell lines were determined. They 
decreased significantly in SF-treated LLC-PK1 cells as compared 
with controls (p < 0.0001), whilst there also was a significant 
decrease in GSH in SF-treated MDBK cells as compared with 
controls (p < 0.0001) (see Figure 1). 
Lipid peroxidation assays
In order to determine whether mitochondrial damage and 
cytotoxicity were related to oxidative stress, we measured the 
























Phulukdaree, Moodley & Chuturgoon
57 Vol. 106    No. 1/2     Page 4 of 5
a byproduct of metabolic pathways such as glycolysis and the 
Krebs cycle.23 The anti-diabetic and favourable cellular metabolic 
properties of SF were previously demonstrated in male Wistar 
rats.24 
The hypoglycaemic potential of SF was shown in diabetogenic 
rats, where it exhibited properties similar to those of the extracts 
similar to those of metformin, the common diabetes type-2 
drug.24 SF extracts increased the uptake of glucose by the kidney 
and resulted in increased glycolysis, which increased the rate 
of the Krebs cycle and produced more reducing equivalents 
(NADH and FADH2). The high concentration of reducing 
equivalents donate electrons to the electron transport chain 
(ETC), resulting in increased ATP production via oxidative 
phosphorylation. This increased ATP concentration, is utilised 
for the active reabsorption of substances by the PCT and DCT. 
The continuous flux of electrons along the ETC and pumping 
of protons out of the matrix results in a negative mitochondrial 
membrane potential, during which process reactive oxygen 
species (ROS) are generated as a byproduct, rendering the 
mitochondria susceptible to oxidative damage.25 
Free radicals attack polyunsaturated fatty acids, a major 
component of cell membranes, thereby forming lipid peroxyl 
radicals. Lipid peroxidation is initiated when the reactive lipid 
peroxyl radicals are not detoxified by antioxidants. The lipid 
alkoxyl radical undergoes cyclisation forming an intermediate 
product which can degrade into MDA.26 Lipid peroxides can 
be detoxified by conjugation to antioxidant molecules such as 
ascorbic acid, α-tocopherol, uric acid and GSH.27 Glutathione 
concentrations were significantly decreased in SF-treated LLC-
PK1 and MDBK cells with a corresponding increase in lipid 
peroxidation compared to the controls (p < 0.0001).
Both the LLC-PK1 and MDBK cells were transformed cell lines 
which proliferated rapidly and possessed high metabolic activity 
which resulted in increased production of ROS, which, when 
not sequestered rapidly, increased lipid peroxidation. The MDA 
concentrations in the control LLC-PK1 and MDBK cells were 0.14 
mM and 3.0 mM, respectively (see Figures 2A and 2B), whereas 
the concentrations of GSH in LLC-PK1 and MDBK cells were 2.85 
µM and 2.1 µM. respectively (see Figure 1). The increased basal 
GSH concentration in the LLC-PK1 cells suggested that these 
cells were better protected from increased ROS production and 
subsequent peroxidation than the MDBK cells were. 
The oxidative ability of L-canavanine to induce ROS and 
ensuing lipid peroxidation was determined previously in a 
mouse glial cell line (N11)27. In this study, a luminol-amplified 
chemiluminescence assay showed that 1 mM of L-canavanine 
significantly (p < 0.05) increased ROS production and lipid 
peroxidation in N11 cells.27 L-canavanine, a structural analogue 
of L-arginine, is a competitive inhibitor of arginine-utilising 
enzymes such as nitric oxide (NO) synthase, which synthesises 
NO from L-arginine.28 Nitric oxide is involved in many biological 
processes and has the ability to spontaneously react with 
superoxide radicals to produce peroxynitrite and subsequently, 
nitrate.27 Nitric oxide, therefore, serves as a reactive radical 
scavenger that ultimately prevents oxidative damage to cellular 
components.29 The possible decreased activity of NO synthase 
and inhibition of NO synthesis by SF may explain the significant 
lipid peroxidation in these renal cell lines. 
Another possibility for the increased lipid peroxidation in 
both the SF-treated LLC-PK1 and MDBK cells may be due to a 
decreased ∆Ψm. GABA was shown to penetrate up to 60% of 
the mitochondrial matrix volume in rat brain and liver cells. 
The weak acidic nature of GABA may contribute to the proton 
gradient disruption within mitochondria.30 A change in ∆Ψm 
promotes formation of ROS as it offsets the normal functioning 
of the ETC. 
In addition to its acidic nature, high concentrations of GABA 
cause the reduction of intra-mitochondrial NAD+ stimulated by 
glutamate.30 Excessive intra-mitochondrial NADH is dissipated 
by donating its electrons to the ETC. The metabolism of GABA 
involves the enzymes GABA: pyruvate transaminase, GABA: 
α-ketogluterate transaminase and succinic semialdehyde 
dehydrogenase to form succinate which can enter the Krebs 
cycle and produce substrates for the ETC.14 
ROS production in the mitochondria increases susceptibility 
for membrane damage, altering the mitochondrial permeability 
transition. This may account for the high percentage of 
depolarised mitochondria noted after treatment of cells with SF 
extracts. The alteration of the ∆Ψm within a cell will not, however, 
occur simultaneously to all the mitochondria that are present.31 
The number of mitochondria that are affected determines the 
amount of ATP generated and the ultimate fate of the cell. The 
amount of ATP available will determine the type of cell death 
that occurs within the cell.20 
When mitochondrial membranes are depolarised, pro-apoptotic 
signals are released. It was demonstrated that changes in ∆Ψm 
favoured the transition of a tightly bound form of cytochrome 
c (to cardiolipin in the inner mitochondrial membrane) into 
its loosely bound form, followed by the release of cytochrome 
c into the extra-mitochondrial environment.32 The release 
of cytochrome c, Apaf-1 and calcium ions into the cytosol 
results in the activation of downstream caspases that execute 
apoptosis.25,33,34 This study showed that SF-extract treatments 
increased caspase-3/7 activity in both cell lines (by 11.9-fold in 
LLC-PK1cells and by 2.2-fold in MDBK cells). 
When comparing the change in ∆Ψm of LLC-PK1 and MDBK 
cells with caspase-3/7 activity, it became evident that SF extracts 
are potent apoptotic inducers. The percentage mitochondrial 
membrane depolarisation in both cell lines appears to be equal 
at basal levels; following SF-extract treatments, an almost similar 
increase in depolarisation occurs in both LLC-PK1 and MDBK 
cells. 
The 11.9-fold increase of caspase activity in LLC-PK1, as 
compared to a 2.2-fold increase in MDBK cells, may be due to the 
difference in mitochondrial numbers and cellular architecture 
of both cell lines. It is known that PCT epithelium contains 
more mitochondria than do DCT cells. The depolarisation 
of mitochondria allows for the increased release of more pro-
apoptotic signals, thereby resulting in increased apoptosis.
TABLE 2
Caspase-3/7 activity of PCT and DCT cells incubated with SF for 48 h. 
RLU – relative light units
Control – Caspase-3/7 
activity (RLU)






LLC-PK1 16 127 ± 346 191 706 ± 13455*** 11.9
p < 
0.0001





Depolarised mitochondria determined by the JC-1 Mitoscreen assay of control and 
SF-treated LLC-PK1 and MDBK cells  
Both cell lines contained approximately 50% depolarised mitochondria without SF treatment. 
Results are presented as the mean ± s.d. and n = 15 000. (***p < 0.0001).
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There exists a real concern about the unregulated use of the 
crude plant derivatives of SF. Evidence that the recommended 
dosages are in such concentrations that they may be potentially 
harmful to the renal tubular cells, could be attained in vivo. 
Ojewole determined that SF extract had an LD50 of 1 280 mg/kg body 
weight in rats.35 In a clinical trial on ten healthy adults receiving 
a dose of 800 mg/day of SF extract, no significant changes in 
haematological, physiological and biochemical markers were 
noted after three months of treatment.36 The only changes 
observed in this in vivo study were a decrease in respiratory rate 
(p < 0.04), and increases in platelet count (p < 0.05), mean cell 
haemoglobin (p = 0.01), protein (p < 0.03) and albumin levels
(p < 0.03).36 Chronic doses of SF extract, however, may eventually 
lead to renal toxicity.
 CONCLUSION
The aqueous SF extracts studied here were not cytotoxic at low 
concentrations, but had the potential to increase oxidative stress, 
alter the integrity of mitochondrial membranes, and promote 
apoptosis in renal tubule epithelia at high concentrations in 
vitro.
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